האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

amryt pharmaceuticals dac - lomitapide - hypercholesterolemia - lipid modifying agents - lojuxta is indicated as an adjunct to a low‑fat diet and other lipid‑lowering medicinal products with or without low-density-lipoprotein (ldl) apheresis in adult patients with homozygous familial hypercholesterolaemia (hofh). genetic confirmation of hofh should be obtained whenever possible. other forms of primary hyperlipoproteinaemia and secondary causes of hypercholesterolaemia (e.g. nephrotic syndrome, hypothyroidism) must be excluded.,

האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

amgen europe b.v. - evolocumab - dyslipidemias; hypercholesterolemia - lipid modifying agents - hypercholesterolaemia and mixed dyslipidaemiarepatha is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin or,alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.homozygous familial hypercholesterolaemiarepatha is indicated in adults and adolescents aged 12 years and over with homozygous familial hypercholesterolaemia in combination with other lipid-lowering therapies.established atherosclerotic cardiovascular diseaserepatha is indicated in adults with established atherosclerotic cardiovascular disease (myocardial infarction, stroke or peripheral arterial disease) to reduce cardiovascular risk by lowering ldl-c levels, as an adjunct to correction of other risk factors:in combination with the maximum tolerated dose of a statin with or without other lipid-lowering therapies or,alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.for study results with respect to effects on ldl-c, cardiovascular events and populations studied see section 5.1.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

tasman pacific holding pty ltd - ascorbic acid,chromic chloride hexahydrate,citrus aurantium,palm tocotrienols complex,sugar cane wax alcohols -

קנדה - אנגלית - Health Canada

mediherb inc. - cholesterol; taraxacum officinale weber; milk thistle; celandine; goldenrod; radish - liquid - 18x; 3x; 3x; 3x; 2x; 3x - cholesterol 18x; taraxacum officinale weber 3x; milk thistle 3x; celandine 3x; goldenrod 2x; radish 3x - homeopathic products

האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - bempedoic acid - hypercholesterolemia; dyslipidemias - lipid modifying agents - nilemdo is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl c goals with the maximum tolerated dose of a statin (see sections 4.2, 4.3, and 4.4) or,alone or in combination with other lipid-lowering therapies in patients who are statin intolerant, or for whom a statin is contraindicated.

האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - bempedoic acid, ezetimibe - hypercholesterolemia; dyslipidemias - lipid modifying agents - nustendi is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin in addition to ezetimibealone in patients who are either statin-intolerant or for whom a statin is contraindicated, and are unable to reach ldl-c goals with ezetimibe alone,in patients already being treated with the combination of bempedoic acid and ezetimibe as separate tablets with or without statin

האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipid modifying agents - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

ultragenyx germany gmbh - evinacumab - hypercholesterolemia - lipid modifying agents - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

nature's care manufacture pty limited - olea europaea, quantity: 20 mg (equivalent: olea europaea, qty 500 mg); cynara scolymus, quantity: 60 mg (equivalent: cynara scolymus, qty 3 g); citrus aurantium, quantity: 250 mg (equivalent: citrus aurantium, qty 50 g; equivalent: oxedrine, qty 5 ng); d-alpha-tocopherol, quantity: 15 mg; vegetable oil phytosterol esters, quantity: 125 mg - capsule, soft - excipient ingredients: sorbitol solution (70 per cent) (non-crystallising); iron oxide black; titanium dioxide; iron oxide red; gelatin; glycerol; soya oil; purified water; iron oxide yellow; yellow beeswax - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support general health and wellbeing ; helps maintain/support healthy cholesterol ; maintain/support cardiovascular system health ; helps maintain/support healthy heart function ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; maintain/support healthy liver function ; maintain/support liver health

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

blackmores ltd - vegetable oil phytosterol esters, quantity: 1 g; betacarotene, quantity: 1.5 mg - capsule, soft - excipient ingredients: glycerol; mixed (low-alpha type) tocopherols concentrate; ascorbyl palmitate; iron oxide red; purified water; soya oil; gelatin; ethanol - maintain/support general health and wellbeing ; helps reduce intestinal absorption of cholesterol from dietary sources ; helps maintain/support healthy cholesterol